Download PDF

1. Company Snapshot

1.a. Company Description

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States.Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management.


It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem.Definitive Healthcare Corp.was founded in 2011 and is headquartered in Framingham, Massachusetts.

Show Full description

1.b. Last Insights on DH

Definitive Healthcare's recent performance was negatively impacted by a lackluster Q4 2025 earnings report, which met analyst expectations but failed to exceed them. The company's revenue of $59.5660 million for the quarter was in line with estimates, but its earnings of $0.06 per share were flat compared to the same period last year. Additionally, the company's consensus rating from brokerages remains a "Hold", with three analysts recommending a sell and three recommending a hold.

1.c. Company Highlights

2. Definitive Healthcare's Q4 2025 Earnings: A Closer Look at Financial Performance

Definitive Healthcare reported revenue of $61.5 million for Q4 2025, exceeding the high end of its guidance range. The company's adjusted EBITDA was $18.1 million, reflecting a margin of 29%. Unlevered free cash flow for the trailing 12 months was approximately $54.9 million. The actual EPS came out at $0.06, in line with estimates. Analysts estimate next year's revenue growth at 0.7%.

Publication Date: Mar -08

📋 Highlights
  • Strong Margin and Cash Flow:: Adjusted EBITDA of $18.1 million (29% margin) and $55 million unlevered free cash flow for the trailing 12 months.
  • Revenue Outperformance:: Q4 revenue of $61.5 million exceeded the high end of guidance, despite a 1% year-over-year decline in subscription revenue.
  • Integration Efficiency Gains:: Partnerships with Snowflake, Databricks, and HubSpot reduced integration time by 25%, enhancing customer satisfaction.
  • 2026 Revenue Guidance:: Full-year revenue projected at $220–226 million (6–9% decline YoY), with Q1 expecting a 5–9% decline due to partial data partnership benefits.
  • Deferred Revenue Growth:: Deferred revenue increased 6% YoY to $99 million, while capitalized software spend rose $5 million to $6 million in 2025.

Revenue Breakdown and Operational Highlights

The company's subscription revenues declined 3% year-over-year, while professional services revenue was strong, up 49% year-over-year. The operational performance was driven by four strategic pillars: data differentiation, integrations, customer success, and innovation. The company deepened its integrations with Snowflake, Databricks, and HubSpot, improving customer satisfaction and reducing integration time by 25%. As Kevin Coop mentioned, "We restarted our organic innovation engine in 2025, resulting in a $6 million increase in capitalized software spend, up from $1 million in the prior year."

Valuation Metrics and Future Outlook

With a P/S Ratio of 0.51 and EV/EBITDA of -0.94, the market seems to have a cautious view on the company's growth prospects. However, the Free Cash Flow Yield of 38.17% indicates that the company is generating significant cash. Looking ahead to 2026, the company expects a 5% to 9% decline in revenue in Q1 compared to Q1 2025. For the full year 2026, the company expects revenue of $220 million to $226 million, a 6% to 9% decline year-over-year.

Guidance and Strategic Priorities

The company's primary strategic objective remains that of returning the business to consistent revenue growth, driven by improving retention and operational performance. The company is confident that its Gen AI enablement of view will provide new and incremental upsell, cross-sell opportunities later this year. The company expects adjusted operating income of $41.5 million to $46.5 million, adjusted EBITDA of $53 million to $58 million, and adjusted net income of $21 million to $26 million in 2026.

Key Takeaways and Investment Implications

The company's focus on organic innovation, AI-enabled products, and integrations is expected to drive growth in the future. While the near-term revenue outlook is challenging, the company's strong cash flow generation and improving retention rates are positive indicators. Investors should closely monitor the company's progress in executing its strategic priorities and improving its top-line growth.

3. NewsRoom

Card image cap

Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript

Feb -27

Source: seekingalpha.com

Card image cap

Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Hold” by Brokerages

Feb -27

Source: defenseworld.net

Card image cap

Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates

Feb -27

Source: zacks.com

Card image cap

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

Feb -26

Source: globenewswire.com

Card image cap

Definitive Healthcare (DH) Projected to Post Quarterly Earnings on Thursday

Feb -19

Source: defenseworld.net

Card image cap

Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of “Hold” from Brokerages

Feb -02

Source: defenseworld.net

Card image cap

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

Jan -29

Source: globenewswire.com

Card image cap

Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

Jan -07

Source: globenewswire.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (4.51%)

6. Segments

Subscription Services

Expected Growth: 4.5%

Definitive Healthcare Corp.'s Subscription Services growth is driven by increasing demand for healthcare data analytics, expansion into new markets, and strategic partnerships. The company's unique data platform, which provides actionable insights to healthcare providers, payers, and life sciences companies, is a key differentiator. Additionally, the shift towards value-based care and the need for data-driven decision making are contributing to the segment's 4.5% growth.

Professional Services

Expected Growth: 4.8%

Definitive Healthcare Corp.'s 4.8% growth in Professional Services is driven by increasing demand for data-driven insights in the healthcare industry, expansion of value-based care models, and growing need for healthcare providers to optimize operations and improve patient outcomes.

7. Detailed Products

Hospital Intelligence

Provides detailed information on hospital market trends, hospital demographics, and hospital purchasing behavior

PhysicianGroup Intelligence

Offers insights into physician group practices, including physician demographics, practice patterns, and prescribing behavior

Surgical Intelligence

Provides detailed data on surgical procedures, including procedure volumes, surgeon demographics, and surgical trends

Claims Analytics

Offers insights into medical claims data, including patient demographics, diagnosis codes, and treatment patterns

Commercial Claims Data

Provides access to commercial claims data, including patient demographics, diagnosis codes, and treatment patterns

Medicare Claims Data

Offers insights into Medicare claims data, including patient demographics, diagnosis codes, and treatment patterns

Diagnostics Intelligence

Provides detailed data on diagnostic testing, including lab test volumes, test types, and testing trends

8. Definitive Healthcare Corp.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Definitive Healthcare Corp. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the evolving nature of the healthcare industry.

Bargaining Power Of Customers

Definitive Healthcare Corp.'s customers are primarily healthcare providers and payers, who have limited bargaining power due to the company's specialized data and analytics offerings.

Bargaining Power Of Suppliers

Definitive Healthcare Corp. has a diversified supplier base, and the company's suppliers have limited bargaining power due to the availability of alternative suppliers.

Threat Of New Entrants

The healthcare data and analytics market is attractive, and new entrants may be drawn to the market, posing a significant threat to Definitive Healthcare Corp.'s market share.

Intensity Of Rivalry

The healthcare data and analytics market is moderately competitive, with several established players, but Definitive Healthcare Corp.'s strong brand and customer relationships help to mitigate the intensity of rivalry.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 23.09%
Debt Cost 6.04%
Equity Weight 76.91%
Equity Cost 10.99%
WACC 9.85%
Leverage 30.02%

11. Quality Control: Definitive Healthcare Corp. passed 5 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Privia Health Group

A-Score: 4.8/10

Value: 2.2

Growth: 8.0

Quality: 5.5

Yield: 0.0

Momentum: 7.0

Volatility: 6.3

1-Year Total Return ->

View Full Report
Stock-Card
CareCloud

A-Score: 4.3/10

Value: 7.2

Growth: 6.9

Quality: 7.1

Yield: 0.0

Momentum: 3.5

Volatility: 1.3

1-Year Total Return ->

View Full Report
Stock-Card
Cue Health

A-Score: 3.8/10

Value: 10.0

Growth: 3.2

Quality: 3.6

Yield: 0.0

Momentum: 6.0

Volatility: 0.0

1-Year Total Return ->

View Full Report
Stock-Card
Definitive Healthcare

A-Score: 3.8/10

Value: 9.2

Growth: 5.3

Quality: 4.4

Yield: 0.0

Momentum: 1.5

Volatility: 2.3

1-Year Total Return ->

View Full Report
Stock-Card
Omnicell

A-Score: 3.1/10

Value: 3.7

Growth: 3.2

Quality: 5.3

Yield: 0.0

Momentum: 2.0

Volatility: 4.3

1-Year Total Return ->

View Full Report
Stock-Card
Ontrak

A-Score: 2.9/10

Value: 10.0

Growth: 4.1

Quality: 3.4

Yield: 0.0

Momentum: 0.0

Volatility: 0.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

1.13$

Current Price

1.13$

Potential

-0.00%

Expected Cash-Flows